Innoget, your Open Innovation partner

First time here

ADVANCELL THERAPEUTICS IBox-in

The IBox-in are requests for innovations - ideas, patents (licensing-in), innovative technologies and products - that companies send to the community Innoget Research Partners. This community includes organizations and individuals, such as research centers, scientists, university researchers and technology companies
Trans

ACCES TO IBox-in

NEW USER

If you have not registered yet and want to access companies that have posted their IBox-in at Innoget, do it now. It's free

Free4_blau
REGISTERED USER

If you are already registered at Innoget, please enter your data:


Trans
Trans
IBox ID >> IB-00092
Industrial sector >> Biotechnology, Pharmaceuticals
Country >> Spain ES
Requested innovation >> Ideas / Patents
Tags >> reprofiling/reformulation, Orphan Drugs, NCE with an evidence of safety/efficay, oncology, dermatolgy, immunomodulation

Company profile

Advancell therapeutics is focused on the development of projects with risk and development costs below the pharma industry standards. our goal is to detect opportunities from our environment and to design development strategies to bring them to clinics efficiently and results driven.

Iconofletxa2

Your name:
Name of your friend:
E-mail address of your friend:
Your message:
Type the characters you see in the box below
Iconofletxa2
Trans
Innoget is a portal for Open Innovation through which companies and Research Partners - organizations and individuals, such as research centers, scientists, university researchers, inventors and technology companies - from around the world interact to develop and share R&D projects and innovations. The aim is to create a space for collaboration and connection between these groups, where each user participates by choosing its role: Open Company or Research Partner. Connections are made using any of the following tools: Challenges, IBox-in and IBox-out. Trust Innoget as your open innovation innomediary.
© 2009 Innoget